CAS: 14838-15-4; (1S,2R)-(+)-Norphedrine

该化合物是一个具有结构特征的手性化合物,包括附属于甲醇组的苯环和氨基乙基侧链.该化合物具有立体中心,有助于其光学活动,以两种对应形式存在.氨基组的存在表明潜在的基本特性,而乙醇类的氢氧基组可以参与氢联结,影响其溶解性和再活性.通常,这种化合物可能展示生物活动,有可能作为合成药物或其他有机化合物的中间体.具体的立体化学(S)表明在阳性中心周围的原子空间安排,这可能会显著影响化合物在生物系统中的相互作用.

结构式图片

上下游产品

(E)-2-(hydroxyimino)-1-phenylpropan-1-one 2-nitro-1-phenylpropan-1-ol 3-chloro-1-phenyl-propane-1,2-dione-2-oxime 3-hydroxy-1-phenyl-2-(2-phenylhydrazono)propan-1-oneerythro-2-trans-cinnamylamino-1-phenyl-propanol-(1)(+/-)-erythro-2-trans-cinnamylamino-1-phenyl-propanol-(1) (+/-)-N-methylephedrine cis-4-methyl-5-phenyl-oxazolidinecis-4-methyl-5-phenyl-oxazolidine 2,4-dimethyl-5-phenyl-4,5-dihydro-oxazole

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7247752-B2
    优先权日:2004-10-01
    标 题 :Methods for the synthesis of astaxanthin
    发明人:LOCKWOOD SAMUEL F; TANG PENG CHO; NADOLSKI GEOFF; JACKSON HENRY L; FANG ZHIQIANG; DU YISHU; YANG MIN; GEISS WILLIAM; WILLIAMS RICHARD; BURDICK DAVID
    权利人:CARDAX PHARMACEUTICALS INC
    摘要:A method used for synthesizing intermediates for use in the synthesis of carotenoids and carotenoid analogs, and/or carotenoid derivatives. In some embodiments, the invention includes methods for synthesizing optically active intermediates useful for the synthesis of optically active carotenoids. Synthesis of optically active carotenoids, in one embodiment, may be accomplished by forming an optically active dihydroxy intermediate from ketoisopherone. The optically active dihydroxy intermediate may be converted into optically active astaxanthin derivatives.

    专利号:US-5932726-A
    优先权日:1996-12-16
    标 题 :Asymmetric synthesis of benzoxazinones
    发明人:PIERCE MICHAEL ERNEST; CHOUDHURY ANUSUYA; PARSONS JR RODNEY LAWRENCE; RADESCA LILIAN ALICIA
    权利人:DU PONT PHARM CO
    摘要:The present invention provides novel methods for the asymmetric synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (VI-i) ##STR1## which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.

    专利号:US-6040480-A
    优先权日:1997-04-07
    标题 :Asymmetric synthesis of benzoxazinones
    发明人:PIERCE MICHAEL E; CHEN CHENG Y; CHOUDHURY ANUSUYA; RADESCA LILIAN A; TAN LUSHI; ZHAO DALIAN
    权利人:DU PONT PHARM CO
    摘要:The present invention provides novel methods for the asymmetric synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (VI-i) which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.

    专利号:US-5856492-A
    优先权日:1997-01-10
    标题 :Efficient synthesis of a chiral mediator
    发明人:CHEN CHENG YI; XU FENG; TILLYER RICHARD D; ZHAO DALIAN
    权利人:MERCK & CO INC
    摘要:An efficient method for the quantitative preparation and isolation of a compound of formula I ##STR1## or its enantiomer, a chiral mediator used in enantioselective synthesis.

    专利号:US-5962737-A
    优先权日:1997-01-08
    标 题 :2-amino-1-phenylpropanols, stereospecific synthesis thereof, and method of optically resolving the same
    发明人:WEST DANIEL DAVID
    摘要:Stereospecific synthesis of the racemic threo isomers of 2-nitro-1-phenylpropanols by reacting a benzaldehyde derivative with nitroalkane in the presence of a tertiary amine and reducing 2-nitro-1-phenylpropanols with, for example, lithium aluminum hydride to 2-amino-1-phenylpropanols is described. Also described are phase transfer resolution of racemic mixtures of 2-amino-1-phenylpropanol and its derivatives into their optically pure isomers by reacting a racemic mixture with the mono alkali metal salt of a tartaric acid ester in a two phase system of a hydrocarbon and water. The specification further describes therapeutically useful optically pure isomers of threo-2-amino-1-(dialkoxy or alkoxy) phenylpropanols and acid addition salts thereof.

    专利号:US-2004110957-A1
    优先权日:2002-12-05
    标 题 :Process for the synthesis of an antiviral compound
    发明人:WILKEN JOERG; NERENZ FRANK; KANSCHIK-CONRADSEN ANDREAS
    权利人:HONEYWELL INT INC
    摘要:In a process comprising synthesizing pyranes including [R—(R*,R*)]-N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide the present invention comprises the improvements comprising: (a) providing a racemic mixture of 3-hydroxy-3-(2-phenylethyl)-hexanoate ethyl acetate by reacting said 1-phenyl-hexan-3-one with ethylbromoacetate under Reformatsky conditions; and (b) separating (R)-3-hydroxy-3-(2-phenylethyl)-hexanoic acid in enantiomeric excess by saponification and reverse resolution of the racemate of step (a) to produce a resolved product. In addition, the present invention comprises a reverse resolution process for separating an enantiomer from a mixture of enantiomers.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.2165/11530130-000000000-00000
    摘要:Hasnain M, Vieweg WV, Fredrickson SK. Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions. CNS Drugs. 2010 Mar;24(3):193–206. doi: 10.2165/11530130-000000000-00000.
    参考文献:10.1007/s00467-011-1964-0
    摘要:Chandar J, Zilleruelo G. Hypertensive crisis in children. Pediatr Nephrol. 2012 May;27(5):741–51. doi: 10.1007/s00467-011-1964-0.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知